Episode Details

Back to Episodes
ORTHO Regenerative Technologies Is Preparing for The Big League, Appointing Patrick O’Donnell to Help Bring its Proprietary Surgery Tech to NASDAQ

ORTHO Regenerative Technologies Is Preparing for The Big League, Appointing Patrick O’Donnell to Help Bring its Proprietary Surgery Tech to NASDAQ

Season 3 Episode 45 Published 5 years, 8 months ago
Description

Last week we introduced you to ORTHO Regenerative Technologies, a  cutting-edge med tech firm that uses its proprietary RESTORE technology  platform to dramatically improve the success rate of orthopedic and  sports medicine surgeries.

  • In layman’s terms, that means company has a wonder delivery  platform that delivers biologics – drugs made from biological processes –  to repair soft tissues in the human body.

Now the firm has appointed Patrick O’Donnell to its board of directors.

  • O’Donnell comes with significant company-building experience
  • He will prove crucial in putting this healthcare pioneer on-track for a NASDAQ listing

Claude LeDuc, Ortho’s CEO, breaks down the appointment:

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us